FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Orthop Res / Genetic modification of scAAV-equine-BMP-2 transduced bone-m...
Journal of orthopaedic research : official publication of the Orthopaedic Research Society2019; 37(6); 1310-1317; doi: 10.1002/jor.24209

Genetic modification of scAAV-equine-BMP-2 transduced bone-marrow-derived mesenchymal stem cells before and after cryopreservation: An “off-the-shelf” option for fracture repair.

Abstract: Optimizing the environment of complex bone healing and improving treatment of catastrophic bone fractures and segmental bone defects remains an unmet clinical need both human and equine veterinary medical orthopaedics. The objective of this study was to determine whether scAAV-equine-BMP-2 transduced cells would induce osteogenesis in equine bone marrow derived mesenchymal stem cells (BMDMSCs) in vitro, and if these cells could be cryopreserved in an effort to osteogenically prime them as an "off-the-shelf" gene therapeutic approach for fracture repair. Our study found that transgene expression is altered by cell expansion, as would be expected by a transduction resulting in episomal transgene expression, and that osteoinductive levels could still be achieved 5 days after recovery, and protein expression would continue up to 14 days after transduction. This is the first evidence that cryopreservation of genetically modified BMDMSCs would not alter the osteoinductive potential or clinical use of allogeneic donor cells in cases of equine fracture repair. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1310-1317, 2019.
© 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Get Full Text
Publication Date: 2019-02-21 PubMed ID: 30578639PubMed Central: PMC8366205DOI: 10.1002/jor.24209Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studied the potential of genetically-modified, bone marrow derived mesenchymal stem cells for use in bone fracture repair for humans and horses, finding that cryopreservation did not affect the cells’ ability to promote bone growth.

Introduction to the Research Topic

  • The study sought to improve the treatment of complex bone fractures and segmental bone defects, which remain challenging for both human and equine orthopaedics.
  • The researchers tried to induce bone growth in horse bone marrow derived mesenchymal stem cells (BMDMSCs), a type of cells that can develop into bone, using genetically transduced cells with a gene called scAAV-equine-BMP-2.

Cryopreservation and Genetic Modification

  • This study also investigated whether these genetically modified cells could be effectively cryopreserved, i.e., frozen for storage and later use.
  • If successful, this could lead to a readily available “off-the-shelf” gene therapeutic approach for fracture repair.

Key Findings

  • The results demonstrated that the gene expression in the genetically modified BMDMSCs was altered when the cells were multiplied or expanded. This is typical of cells that have undergone gene transduction, a process that brings foreign DNA into cells.
  • However, the researchers discovered that even after cell expansion, bone growth-promoting (osteoinductive) levels could still be achieved in the cells 5 days after being thawed from cryopreservation, and protein expression continued for up to 14 days after gene transduction.

Significance of the Study

  • This is the first study to show that cryopreservation of genetically modified BMDMSCs does not have any significant impact on their osteoinductive potential or their ability to be used clinically in fracture repairs.
  • The successful preservation of these cells means that they could be made readily available as an “off-the-shelf” treatment option for fractures, potentially leading to more effective and quicker recovery for human and equine patients.

Cite This Article

APA
Ball AN, Phillips JN, McIlwraith CW, Kawcak CE, Samulski RJ, Goodrich LR. (2019). Genetic modification of scAAV-equine-BMP-2 transduced bone-marrow-derived mesenchymal stem cells before and after cryopreservation: An “off-the-shelf” option for fracture repair. J Orthop Res, 37(6), 1310-1317. https://doi.org/10.1002/jor.24209

Publication

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
ISSN: 1554-527X
NlmUniqueID: 8404726
Country: United States
Language: English
Volume: 37
Issue: 6
Pages: 1310-1317

Researcher Affiliations

Ball, Alyssa N
  • Orthopaedic Research Center, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Phillips, Jennifer N
  • Orthopaedic Research Center, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
McIlwraith, C Wayne
  • Orthopaedic Research Center, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Kawcak, Christopher E
  • Orthopaedic Research Center, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Samulski, Richard J
  • Gene Therapy Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Goodrich, Laurie R
  • Orthopaedic Research Center, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.

MeSH Terms

  • Animals
  • Bone Morphogenetic Protein 2 / genetics
  • Cryopreservation
  • Dependovirus / genetics
  • Fracture Healing
  • Genetic Therapy / methods
  • Horses
  • Transduction, Genetic

Grant Funding

  • T32 OD012201 / NIH HHS

References

This article includes 45 references
  1. Ball AN, Donahue SW, Wojda SJ, McIlwraith CW, Kawcak CE, Ehrhart N, Goodrich LR. The challenges of promoting osteogenesis in segmental bone defects and osteoporosis.. J Orthop Res 2018 Jun;36(6):1559-1572.
    pmc: PMC8354209pubmed: 29280510doi: 10.1002/jor.23845google scholar: lookup
  2. Ahern BJ, Richardson DW, Boston RC, Schaer TP. Orthopedic infections in equine long bone fractures and arthrodeses treated by internal fixation: 192 cases (1990-2006).. Vet Surg 2010 Jul;39(5):588-93.
    pubmed: 20459481doi: 10.1111/j.1532-950X.2010.00705.xgoogle scholar: lookup
  3. Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC, He TC. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.. J Orthop Res 2007 May;25(5):665-77.
    pubmed: 17290432doi: 10.1002/jor.20359google scholar: lookup
  4. Wei S, Cai X, Huang J, Xu F, Liu X, Wang Q. Recombinant human BMP-2 for the treatment of open tibial fractures.. Orthopedics 2012 Jun;35(6):e847-54.
    pubmed: 22691656doi: 10.3928/01477447-20120525-23google scholar: lookup
  5. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N. Osteoinductivity of gelatin/β-tricalcium phosphate sponges loaded with different concentrations of mesenchymal stem cells and bone morphogenetic protein-2 in an equine bone defect model.. Vet Res Commun 2014 Mar;38(1):73-80.
    pubmed: 24442646doi: 10.1007/s11259-013-9587-5google scholar: lookup
  6. Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.. Health Technol Assess 2007 Aug;11(30):1-150, iii-iv.
    pubmed: 17669279doi: 10.3310/hta11300google scholar: lookup
  7. Evans CH. Gene therapy for bone healing.. Expert Rev Mol Med 2010 Jun 23;12:e18.
    pmc: PMC4339214pubmed: 20569532doi: 10.1017/S1462399410001493google scholar: lookup
  8. Yazici C, Takahata M, Reynolds DG, Xie C, Samulski RJ, Samulski J, Beecham EJ, Gertzman AA, Spilker M, Zhang X, O'Keefe RJ, Awad HA, Schwarz EM. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.. Mol Ther 2011 Aug;19(8):1416-25.
    pmc: PMC3149158pubmed: 21206485doi: 10.1038/mt.2010.294google scholar: lookup
  9. Evans CH, Ghivizzani SC, Robbins PD. Arthritis Gene Therapy Approved in Korea.. J Am Acad Orthop Surg 2018 Jan 15;26(2):e36-e38.
    pubmed: 29303924doi: 10.5435/JAAOS-D-17-00695google scholar: lookup
  10. McCarty DM. Self-complementary AAV vectors; advances and applications.. Mol Ther 2008 Oct;16(10):1648-56.
    pubmed: 18682697doi: 10.1038/mt.2008.171google scholar: lookup
  11. Hemphill DD, McIlwraith CW, Samulski RJ, Goodrich LR. Adeno-associated viral vectors show serotype specific transduction of equine joint tissue explants and cultured monolayers.. Sci Rep 2014 Jul 29;4:5861.
    pmc: PMC4894424pubmed: 25069854doi: 10.1038/srep05861google scholar: lookup
  12. Guest DJ, Ousey JC, Smith MR. Defining the expression of marker genes in equine mesenchymal stromal cells.. Stem Cells Cloning 2008;1:1-9.
    pmc: PMC3781685pubmed: 24198500doi: 10.2147/sccaa.s3824google scholar: lookup
  13. Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.. Vet Immunol Immunopathol 2013 Nov 15;156(1-2):99-106.
    pubmed: 24094688doi: 10.1016/j.vetimm.2013.09.003google scholar: lookup
  14. Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.. Vet Comp Orthop Traumatol 2013;26(6):453-60.
    pubmed: 24080668doi: 10.3415/VCOT-13-01-0008google scholar: lookup
  15. Lombana KG, Goodrich LR, Phillips JN, Kisiday JD, Ruple-Czerniak A, McIlwraith CW. An Investigation of Equine Mesenchymal Stem Cell Characteristics from Different Harvest Sites: More Similar Than Not.. Front Vet Sci 2015;2:67.
    pmc: PMC4672231pubmed: 26664993doi: 10.3389/fvets.2015.00067google scholar: lookup
  16. Zachos TA, Shields KM, Bertone AL. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.. J Orthop Res 2006 Jun;24(6):1279-91.
    pubmed: 16649180doi: 10.1002/jor.20068google scholar: lookup
  17. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.. J Bone Joint Surg Am 1999 Jul;81(7):905-17.
    pubmed: 10428121doi: 10.2106/00004623-199907000-00002google scholar: lookup
  18. Hsu WK, Sugiyama O, Park SH, Conduah A, Feeley BT, Liu NQ, Krenek L, Virk MS, An DS, Chen IS, Lieberman JR. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats.. Bone 2007 Apr;40(4):931-8.
    pubmed: 17236835doi: 10.1016/j.bone.2006.10.030google scholar: lookup
  19. Virk MS, Sugiyama O, Park SH, Gambhir SS, Adams DJ, Drissi H, Lieberman JR. "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair.. Mol Ther 2011 May;19(5):960-8.
    pmc: PMC3098640pubmed: 21343916doi: 10.1038/mt.2011.2google scholar: lookup
  20. Johnson RG. Bone marrow concentrate with allograft equivalent to autograft in lumbar fusions.. Spine (Phila Pa 1976) 2014 Apr 20;39(9):695-700.
    pubmed: 24503679doi: 10.1097/BRS.0000000000000254google scholar: lookup
  21. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M, Ghivizzani SC, Robbins PD, Evans CH. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene.. Gene Ther 2000 May;7(9):734-9.
    pubmed: 10822299doi: 10.1038/sj.gt.3301166google scholar: lookup
  22. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans CH. Direct percutaneous gene delivery to enhance healing of segmental bone defects.. J Bone Joint Surg Am 2006 Feb;88(2):355-65.
    pubmed: 16452748doi: 10.2106/JBJS.E.00464google scholar: lookup
  23. Southwood LL, Kawcak CE, Hidaka C, McIlwraith CW, Werpy N, Macleay J, Frisbie DD. Evaluation of direct in vivo gene transfer in an equine metacarpal IV ostectomy model using an adenoviral vector encoding the bone morphogenetic protein-2 and protein-7 gene.. Vet Surg 2012 Apr;41(3):345-54.
    pubmed: 22308976doi: 10.1111/j.1532-950X.2011.00947.xgoogle scholar: lookup
  24. Virgin JE, Goodrich LR, Baxter GM, Rao S. Incidence of support limb laminitis in horses treated with half limb, full limb or transfixation pin casts: a retrospective study of 113 horses (2000-2009).. Equine Vet J Suppl 2011 Nov;(40):7-11.
    pubmed: 22082439doi: 10.1111/j.2042-3306.2011.00491.xgoogle scholar: lookup
  25. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.. Stem Cell Res Ther 2014 Jan 24;5(1):13.
    pmc: PMC4055004pubmed: 24461709doi: 10.1186/scrt402google scholar: lookup
  26. Colbath AC, Dow SW, Phillips JN, McIlwraith CW, Goodrich LR. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.. Stem Cells Dev 2017 Apr 1;26(7):503-511.
    pubmed: 27958776doi: 10.1089/scd.2016.0266google scholar: lookup
  27. Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. Immunol Cell Biol 2013 Jan;91(1):40-51.
    pubmed: 23207278doi: 10.1038/icb.2012.67google scholar: lookup
  28. Broeckx S, Borena BM, Zimmerman M, Mariën T, Seys B, Suls M, Duchateau L, Spaas JH. Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients.. Curr Stem Cell Res Ther 2014;9(6):452-7.
    pubmed: 24548143doi: 10.2174/1574888x09666140220003847google scholar: lookup
  29. Broeckx S, Suls M, Beerts C, Vandenberghe A, Seys B, Wuertz-Kozak K, Duchateau L, Spaas JH. Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study.. Curr Stem Cell Res Ther 2014;9(6):497-503.
    pubmed: 25175766doi: 10.2174/1574888x09666140826110601google scholar: lookup
  30. Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, Leleu X, De Becker A, Van Camp B, Croucher P, Vanderkerken K, Van Riet I. Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.. Acta Pharmacol Sin 2013 May;34(5):699-709.
    pmc: PMC4002867pubmed: 23564084doi: 10.1038/aps.2012.182google scholar: lookup
  31. Evans C. Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues.. Int Orthop 2014 Sep;38(9):1761-9.
    pmc: PMC4339186pubmed: 25038968doi: 10.1007/s00264-014-2423-xgoogle scholar: lookup
  32. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG, Hidaka C. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.. Bone 2006 Jul;39(1):61-71.
    pmc: PMC2943335pubmed: 16488673doi: 10.1016/j.bone.2005.12.018google scholar: lookup
  33. Pensak M, Hong S, Dukas A, Tinsley B, Drissi H, Tang A, Cote M, Sugiyama O, Lichtler A, Rowe D, Lieberman JR. The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur.. Gene Ther 2015 Jun;22(6):467-75.
    pubmed: 25809463doi: 10.1038/gt.2015.14google scholar: lookup
  34. Ishihara A, Weisbrode SE, Bertone AL. Autologous implantation of BMP2-expressing dermal fibroblasts to improve bone mineral density and architecture in rabbit long bones.. J Orthop Res 2015 Oct;33(10):1455-65.
    pmc: PMC4441610pubmed: 25418909doi: 10.1002/jor.22791google scholar: lookup
  35. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration.. Biomaterials 2009 May;30(14):2816-25.
    pubmed: 19232714doi: 10.1016/j.biomaterials.2009.01.031google scholar: lookup
  36. Goodrich LR, Grieger JC, Phillips JN, Khan N, Gray SJ, McIlwraith CW, Samulski RJ. scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.. Gene Ther 2015 Jul;22(7):536-45.
    pmc: PMC5567794pubmed: 25902762doi: 10.1038/gt.2015.21google scholar: lookup
  37. Kay JD, Gouze E, Oligino TJ, Gouze JN, Watson RS, Levings PP, Bush ML, Dacanay A, Nickerson DM, Robbins PD, Evans CH, Ghivizzani SC. Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus.. J Gene Med 2009 Jul;11(7):605-14.
    pmc: PMC2876984pubmed: 19384892doi: 10.1002/jgm.1334google scholar: lookup
  38. Buie LK, Rasmussen CA, Porterfield EC, Ramgolam VS, Choi VW, Markovic-Plese S, Samulski RJ, Kaufman PL, Borrás T. Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys.. Invest Ophthalmol Vis Sci 2010 Jan;51(1):236-48.
    pmc: PMC2869048pubmed: 19684004doi: 10.1167/iovs.09-3847google scholar: lookup
  39. Clarke B. Normal bone anatomy and physiology.. Clin J Am Soc Nephrol 2008 Nov;3 Suppl 3(Suppl 3):S131-9.
    pmc: PMC3152283pubmed: 18988698doi: 10.2215/CJN.04151206google scholar: lookup
  40. Glynn ER, Londono AS, Zinn SA, Hoagland TA, Govoni KE. Culture conditions for equine bone marrow mesenchymal stem cells and expression of key transcription factors during their differentiation into osteoblasts.. J Anim Sci Biotechnol 2013 Oct 29;4(1):40.
    pmc: PMC3874597pubmed: 24169030doi: 10.1186/2049-1891-4-40google scholar: lookup
  41. Carpenter RS, Goodrich LR, Frisbie DD, Kisiday JD, Carbone B, McIlwraith CW, Centeno CJ, Hidaka C. Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone.. J Orthop Res 2010 Oct;28(10):1330-7.
    pmc: PMC3200399pubmed: 20309952doi: 10.1002/jor.21126google scholar: lookup
  42. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds.. Biochem Biophys Res Commun 2002 Mar 22;292(1):144-52.
    pubmed: 11890685doi: 10.1006/bbrc.2002.6623google scholar: lookup
  43. Evans CH, Liu FJ, Glatt V, Hoyland JA, Kirker-Head C, Walsh A, Betz O, Wells JW, Betz V, Porter RM, Saad FA, Gerstenfeld LC, Einhorn TA, Harris MB, Vrahas MS. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage.. Eur Cell Mater 2009 Dec 31;18:96-111.
    pmc: PMC4382019pubmed: 20073015doi: 10.22203/ecm.v018a09google scholar: lookup
  44. Alaee F, Sugiyama O, Virk MS, Tang H, Drissi H, Lichtler AC, Lieberman JR. Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.. Gene Ther 2014 Feb;21(2):139-47.
    pmc: PMC4896754pubmed: 24285218doi: 10.1038/gt.2013.66google scholar: lookup
  45. Esteves CL, Sheldrake TA, Mesquita SP, Pesántez JJ, Menghini T, Dawson L, Péault B, Donadeu FX. Isolation and characterization of equine native MSC populations.. Stem Cell Res Ther 2017 Apr 18;8(1):80.
    pmc: PMC5395828pubmed: 28420427doi: 10.1186/s13287-017-0525-2google scholar: lookup

Citations

This article has been cited 4 times.
  1. Zhu L, Liu Y, Wang A, Zhu Z, Li Y, Zhu C, Che Z, Liu T, Liu H, Huang L. Application of BMP in Bone Tissue Engineering.. Front Bioeng Biotechnol 2022;10:810880.
    doi: 10.3389/fbioe.2022.810880pubmed: 35433652google scholar: lookup
  2. Kingsley NB, Hamilton NA, Lindgren G, Orlando L, Bailey E, Brooks S, McCue M, Kalbfleisch TS, MacLeod JN, Petersen JL, Finno CJ, Bellone RR. "Adopt-a-Tissue" Initiative Advances Efforts to Identify Tissue-Specific Histone Marks in the Mare.. Front Genet 2021;12:649959.
    doi: 10.3389/fgene.2021.649959pubmed: 33841506google scholar: lookup
  3. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases.. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  4. Arthur A, Gronthos S. Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue.. Int J Mol Sci 2020 Dec 21;21(24).
    doi: 10.3390/ijms21249759pubmed: 33371306google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.